Prince Pharmaceutical Co., Ltd. manufactures and sells vitamin B1 active pharmaceutical ingredients (APIs) in Taiwan, Japan, Korea, and internationally. The company also offers health food and medicines; vitamin c tablets, vitamin b complex tablets, natto and rhodiola extract capsules, probiotic sachets, and plant extract capsules; and API products comprising felbinac, aldioxa, tulobuterol, ufenamate, bisbentiamine, thiamine disulfide, potassium guaiacolsulfonate, potassium cresolsulfonate, fusultiamine hydrochloride, and fursultiamine. Prince Pharmaceutical Co., Ltd. was founded in 1962 and is headquartered in Yúnlín, Taiwan.
Frequently asked questions
What sector does Prince Pharmaceutical Co., Ltd. (6935) operate in?
Prince Pharmaceutical Co., Ltd. belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Prince Pharmaceutical Co., Ltd. (6935) current stock price?
As of the latest data, Prince Pharmaceutical Co., Ltd. stock price is NT$29.15, with a previous close of NT$29.15.
What is Prince Pharmaceutical Co., Ltd. (6935) current market capitalization?
Prince Pharmaceutical Co., Ltd. market cap is approximately 1.09 billion.
What is Prince Pharmaceutical Co., Ltd. (6935) Earnings Per Share (EPS)?
The trailing EPS is NT$2.61.
What is Prince Pharmaceutical Co., Ltd. (6935) Price-to-Earnings (P/E) ratio?
Prince Pharmaceutical Co., Ltd. current P/E ratio is 11.17.
Does Prince Pharmaceutical Co., Ltd. (6935) pay dividends?
Yes. Prince Pharmaceutical Co., Ltd. pays annual dividends with an annualized yield of 1.72% and an estimated annual payout of NT$0.50 per share.
When is the next ex-dividend date for Prince Pharmaceutical Co., Ltd. (6935)?
The next ex-dividend date is scheduled for July 01, 2027.
What is Prince Pharmaceutical Co., Ltd. (6935) beta (volatility) score?
Prince Pharmaceutical Co., Ltd. has a beta of 0.628, indicating lower volatility than the overall market.
